Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Konstantaras

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chest|December 1, 1982
Inferior vena cava thrombosis due to migration of retained functionless pacemaker electrodeM Toumbouras, P Spanos, C Konstantaras, et al.
World Journal of Surgery|March 1, 1981
The effect of highly selective vagotomy on canine gastric mucosal blood flowN B Natsikas, C Konstantaras, K P Psarrakos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group studyD V Skarlos, G Aravantinos, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A Zisiadis, U Dafni, et al.
Oncology|April 15, 2000
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A Zisiadis, U Dafni, et al.
Oncology|March 1, 1996
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group StudyG Fountzilas, A Polichronis, K Katsohis, et al.
Anticancer Research|March 12, 1998
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, S Vasilaros, D Koukouras, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chest|December 1, 1982
Inferior vena cava thrombosis due to migration of retained functionless pacemaker electrodeM Toumbouras, P Spanos, C Konstantaras, et al.
World Journal of Surgery|March 1, 1981
The effect of highly selective vagotomy on canine gastric mucosal blood flowN B Natsikas, C Konstantaras, K P Psarrakos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group studyD V Skarlos, G Aravantinos, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A Zisiadis, U Dafni, et al.
Oncology|April 15, 2000
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A Zisiadis, U Dafni, et al.
Oncology|March 1, 1996
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group StudyG Fountzilas, A Polichronis, K Katsohis, et al.
Anticancer Research|March 12, 1998
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, S Vasilaros, D Koukouras, et al.
Pageof 1